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Of many lipid transfer proteins identified, all have been
implicated in essential cellular processes, but the activity
of none has been demonstrated in intact cells. Among
these, phosphatidylinositol transfer proteins (PITP) are of
particular interest as they can bind to and transfer
phosphatidylinositol (PtdIns) – the precursor of important
signalling molecules, phosphoinositides – and because
they have essential functions in neuronal development
(PITPa) and cytokinesis (PITPb). Structural analysis in-
dicates that, in the cytosol, PITPs are in a ‘closed’ confor-
mation completely shielding the lipid within them. But
during lipid exchange at the membrane, they must
transiently ‘open’. To study PITP dynamics in intact cells,
we chemically targeted their C95 residue that, although
non-essential for lipid transfer, is buried within the
phospholipid-binding cavity, and so, its chemical modifi-
cation prevents PtdIns binding because of steric hin-
drance. This treatment resulted in entrapment of open
conformation PITPs at the membrane and inactivation of
the cytosolic pool of PITPs within few minutes. PITP
isoforms were differentially inactivated with the dynam-
ics of PITPb faster than PITPa. We identify two trypto-
phan residues essential for membrane docking of PITPs.
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Phosphatidylinositol transfer proteins (PITPa and b)a r e
highly conserved 32-kDa soluble proteins that can bind
and transfer phosphatidylinositol (PtdIns) and phosphati-
dylcholine (PtdCho) between cellular membranes in vitro
(1–3). They are ideal candidates for the intracellular
distribution of PtdIns from its site of synthesis, the endo-
plasmic reticulum (ER), to other membrane compart-
ments. Mice deficient in PITPa die shortly after birth
because of neurological defects, while PITPb defici-
ency is embryonically lethal (4–6). PITPa is required for
phospholipase-C- and phosphoinositide-3-kinase-mediated
signalling during axonal outgrowth, whereas PITPb parti-
cipates in delivery of membrane vesicles and maintaining
the actin ring at the cleavage furrow during cytokinesis
(2,7–14).
The two human PITPs are 77% identical and 94% similar
in amino acid sequence. Structurally, soluble PITPa and
PITPb are also very similar (15–17). An eight-stranded
concave b-sheet flanked by two long a helices forms
a hydrophobic cavity that protects a single phospholipid
from the hydrophilic environment of the cytosol (Fig-
ure 1A). An a helix (G-helix), together with 11 C-terminal
amino acid residues, functions as a ‘lid’ to close the
cavity. In the crystal structure of apo-PITPa, structural
changes including repositioning of the G-helix, C-terminal
tail and the ‘lipid-binding loop’ (Figure 1B) suggest that
the apo form may resemble the membrane-associated
form. These changes would expose the hydrophobic
lipid-binding side chains of apo-PITPa monomer, but
interactions with a second PITPa molecule serve to bury
these residues in the dimer interface (18). Also, PITPa
dimerizes when its 24 C-terminus amino acids are pro-
teolytically removed with subtilisin (19), a treatment that
would expose at least some of its hydrophobic side
chains. This PITPa dimer cannot participate in lipid
transfer.
The two lipid cargos of PITPs are PtdIns and PtdCho;
while their headgroups are distinct, they occupy a similar
location within PITPs (15,16). The five available hydroxyl
groups of the inositol ring individually make contact
with four amino acid residues of PITPa, T59, K61, E86
and N90 (Figure 1C) (We follow previous convention (16)
and use the numbering of rat PITPa throughout the paper.
Human PITPa has an almost identical sequence to rat
PITPa with only a single residue deletion at position 52.
This allows for easy comparison between this work and
the previous publications), and mutation of any of these
Re-use of this article is permitted in accordance with the
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out affecting PtdCho binding and transfer (16). Although
close to the inositol-headgroup-binding site (Figure 1C),
C95 is not essential for lipid transfer as C95A mutation
has no effect on lipid transfer ability of PITPa (20).
However, chemical modification of C95 of recombinant
PITPa in vitro with thiol-modifying reagents results in
loss of PtdIns transfer activity (20), probably because
the bound adduct occupies the space required by the
lipid headgroup (Figure 1D). C95 is buried when PITPa is
in the ‘closed’ soluble conformation but becomes ex-
posed and prone to modification when PITPa is allowed
to transiently associate with liposomes during lipid
exchange (20).
Although PITPs can bind and transfer lipids between
membrane compartments in vitro, whether they function
as lipid transfer proteins in vivo has not been established.
Analysis of cellular PITPs only identified the lipid-loaded
forms (7,21), indicating the transient nature of the apo
form. Thus, it is also unknown how frequently PITPs dock
on membranes and undergo a cycle of ‘open’ and closed
conformations, an indicator of lipid exchange in vivo
(Figure 1E). In the case of PITPb, a population is localized
to the Golgi (22,23), but its conformational state is not
known. Because thiol-modifying agents can only access
C95 when PITPa is in the open conformation on liposomes
(20), we used them – n-ethylmaleimide (NEM) and 2,20-
dithiodipyridine (DTDP) – as tools to measure the dynamics
ofPITPinteractionwithmembranesinintactcells.Usingthe
software tool MAPAS (24) to predict membrane-contacting
protein surfaces, optimal docking area prediction on both
PITPa and PITPb identifies the dimer interface, with strong
values for W203/W204 residues. We have tested this
prediction in vivo and find that PITPa and PITPb are unable
to undergo a change to an open conformation at the
membrane when the two tryptophan residues are mutated
to alanine.
Results
PITP dynamics in live cells revealed using the
sulphydryl-modifying reagent, NEM
Because NEM inactivation requires conformational
changes of the protein upon binding a membrane and
modification would prevent lipid exchange, inactivation of
the transfer activity of cytosolic PITP provides an indication
of PITP undergoing conformational change from closed to
open. Intact HL60 cells were treated with NEM for 10 min
and were then disrupted by sonication. The homogenate
was centrifuged to separate membranes and cytosol. The
cytosolic fraction of control cells has robust PtdIns transfer
activity, which was inhibited in the cytosol prepared from
NEM-treated cells (Figure 2A). The distribution of PITPb
between the membranes and the cytosol following NEM
treatment of intact HL60 cells was also examined (HL60
cells predominantly express PITPb (Figure S1). In control
HL60 cells, PITPb was mainly found in the cytosolic
fraction. A very small amount of PITPb that was occasion-
ally found associated with the membranes probably cor-
responds to the Golgi-associated population of this isoform
(Figures 2B and 3A). Following NEM treatment, a signifi-
cant redistribution of PITPb to the membrane fractions
was observed (Figure 2B); PITPb levels increased from 0.2
to 4.1 ng in the membranes (30 mg). This increase was
accompanied by a slight decrease in the PITPb content in
the cytosolic fraction (Figure 2B). Based on densitometric
analysis, we estimate that, upon NEM treatment,  10–
15% of PITPb became membrane associated taking into
consideration the total amount of cytosolic and membrane
proteins present. Therefore, retention of PITPb to mem-
branes alone cannot account for the inhibition of lipid
transfer observed in the cytosol (Figure 2A).
Membrane association of PITPb and inhibition of PtdIns
transfer activity were dependent on both the concentration
of NEM used to treat the HL60 cells and the time of
Figure 1: The C95 residue in PITPa is located close to the lipid-headgroup-binding site. The position of C95 residue is shown in A)
the closed (lipid-bound) and in B) the open (lipid-free) conformations of a PITPa molecule. The lipid-binding core residues are coloured
blue, the G-helix and the extended 11 amino acids at the C-terminus that form the lid are coloured red, the regulatory loop is coloured
green and the lipid exchange loop (18) is coloured grey. C95 is depicted as balls and is coloured yellow; it is inaccessible to small
molecules in the closed conformation (A) but exposed in the apo structure (B). The backbone of the surface residue C188 is coloured
yellow. In the apo structure, the lipid exchange loop and the G-helix have moved to the open configuration and the C-terminal region is
disordered. The side chains of W203 and 204 are coloured orange. The diagrams were generated using the PYMOL software with PDB files
1t27 and 1kcm. C) A stick model showing a PtdIns molecule (magenta carbon atoms) and the functionally important inositol-binding
residues K61, N90, T59 and E86 in the lipid-binding cavity of PITPa. Also, labelled are the four residues that make contact with the
phosphate moiety of the phospholipids, Q22, T97, T114 and K195. C95 (green carbon atoms and yellow sulphur atom) is seen to be in
close proximity to the inositol ring (PDB code: 1UW5). D) Docking of NEM on C95 illustrates that alkylation of C95 would sterically hinder
phospholipid binding. The NEM is shown with yellow carbon atoms and clashes with PtdIns (shown with a pink surface). E) Model for
membrane interactions and lipid exchange by PITPs. 1) Soluble PITP bound to PtdIns in the closed conformation in the cytosol. 2) PITP
initially docks onto a membrane using the two tryptophan residues (WW). 3) Conformational change of PITP at the membrane into an
open form involves movement of the C-terminus and G a-helix, which exposes the hydrophobic surface of the lipid-binding cavity. This
allows lipid exchange of PtdIns for PtdCho to occur. 4) Following lipid exchange, PITP bound to PtdCho undergoes a conformational
change into the closed form. 5) PITP bound to PtdCho in the closed conformation is soluble and freely diffuses away from the membrane.
PtdIns, solid circles; PtdCho, open circles.
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membrane fractions was observed after treatment with
100 mM NEM for 10 min, a concentration that led to
significant inhibition ( 40%) of lipid transfer. Nearly 75%
of the transfer activity was lost with 250 mM NEM, and
near maximal inactivation was observed with 500 mM NEM
(Figure S2A,B). Treatment with 100 mM NEM for 2 min
also caused significant membrane retention of PITPb, and
maximal retention was observed following treatment with
500 mM NEM for 2 min. Significant inhibition of lipid trans-
fer ( 60%) was observed with 500 mM NEM (Figure
S2C,D). In all, the association of PITPb to membranes
was rapid and was observed at much lower concentration
of NEM than that required for inhibition of transfer activity.
We next examined whether PtdIns transfer activity
observed in the cytosolic fraction was primarily because
of PITPs. Cytosol from HL60 cells was separated by size
exclusion chromatography, and the fractions were exam-
ined for both PtdIns and PtdCho transfer activity as well as
by western blot using antibodies for PITPb. A single peak
of PtdIns (and PtdCho) transfer activity present in fractions
20–23 was observed (Figure 2C, see inset). Western blot
analysis of the same fractions revealed that PITPb (and
PITPa, data not shown) eluted in these fractions (Figure
2D, top panel), establishing that the PtdIns transfer activity
in HL60 cytosol is mainly because of the activity of PITPb
with a small contribution from PITPa (Figure S1). Cytosol
was also prepared from NEM-treated HL60 cells and
similarly fractionated by size exclusion chromatography.
Minimal PtdIns or PtdCho transfer activity was observed in
the fractionated cytosol from NEM-treated HL60 cells
(Figure 2C). Western blot analysis of the same fractions
revealed that NEM-modified PITPb eluted as a protein with
a larger than expected Stokes radius although on SDS–
PAGE it still migrated as a 32-kDa protein, similar to PITPb
from control cells. Using molecular weight markers to
calibrate the size exclusion chromatography column, we
calculate that PITPb elutes as a 67-kDa protein – that is,
roughly twice its normal size. This can be rationalized by
assuming that NEM-modified PITPb exists in the hydro-
philic environment of the cytosol as a dimer so that the
hydrophobic residues that would otherwise be exposed in
an apo-PITP-like structure are buried in the dimer interface.
Visualization of PITPb entrapment to the Golgi and
the ER revealed using NEM
PITPb has been reported to localize at the Golgi when
examined by immunofluorescence (21–23,25). However,
Figure 2: Inhibition of PtdIns transfer activity and membrane retention of PITPb following NEM treatment of HL60 cells. HL60
cells weretreatedwith 1 mM NEM for 10 min at 378C, and cytosoland membranes weresubsequentlyprepared. A)PtdInstransferactivity
in cytosol prepared from control (closed circles) and NEM-treated cells (open circles). B) Thirty micrograms of HL60 membranes and
cytosol were analysed by SDS–PAGE, followed by western blot analysis from control and NEM-treated cells. Recombinant PITPb was run
in parallel to quantify the amount of PITPb. The values are indicated above the blot in nanograms. C and D) HL60 cytosol (180 mL) from
control and NEM-treated cells was fractionated by size exclusion chromatography (Superose 12 column 10/300), and the fractions were
assayed for PtdIns and PtdCho transfer activity (inset) (C) and PITPb distribution by western blot analysis (D). The column was calibrated
using a kit containing proteins of molecular weight 200, 67, 43, 25, and 13.7 kDa, and their elution profile is indicated in (D). PITPb in the
cytosol prepared from NEM-treated cells elutes as a 67-kDa protein.
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constantly undergoing changes from closed to open
conformation. We therefore used the rat kidney cell line
normal rat kidney (NRK), which expresses significant
levels of PITPb (Figure S1), and examined localization of
endogenous PITPb upon treatment with 100 mM NEM in
cells fixed prior to permeabilization (Figure 3A,B) and fixed
after permeabilization (Figure 3C,D). PITPb is localized at
the Golgi but additionally shows a diffuse localization
within the cytoplasm and faintly at the nuclear envelope
(Figure 3A). This staining could correspond to PITPb either
associated with the ER or is cytosolic. When the cells are
permeabilized prior to fixation, association of PITPb with
the Golgi observed by immunofluorescence is markedly
reduced (Figure 3C). These results parallel the results
when cells are homogenized and membrane fractions
examined (Figure 2B). To examine whether PITPb is on
the ER membrane, we used low concentrations of NEM
(100 mM) to capture PITPb, followed by examination by
immunofluorescence (Figure 3B,D). This NEM treatment
does not affect the structure of the Golgi (Figure S3). In
NEM-treated cells, PITPb is now retained despite perme-
abilization of the cells prior to fixation (Figure 3D). In
addition to the Golgi-localized PITPb, the diffuse staining
is still observed, indicating that PITPb associates with
the ER compartment as well (Figure 3D). Staining of the
nuclear envelope is also observed (Figure 3D). When the
cells were not permeabilized prior to fixation, NEM
treatment enhanced the staining of the Golgi compared
with non-treated cells (compare Figure 3A and 3B). In
addition, the staining of the nuclear envelope is clearly
observed (Figure 3B).
NEM targets C95 of PITPb, resulting in inhibition of
PtdIns transfer
The thiol-modifying reagent NEM irreversibly alkylates the
sulphydryl group on cysteine residues. In PITPa, only two
of the four cysteine residues present in PITPa (C95 and
C188) can be alkylated by NEM (20). A surface residue,
C188, is always accessible to NEM, and its modification
with NEM does not affect PtdIns transfer activity of PITPa
(20). To demonstrate that NEM exerts its inhibitory effect
by modifying C95 in PITPb and PITPa, we mutated this
residue to either alanine or threonine. C188 was also
mutated to alanine. The mutant proteins were expressed
in Escherichia coli, and the purified recombinant proteins
(Figure S4A,C) were examined for PtdIns transfer (Figure
S4B,D). Wild-type (WT) PITPa and PITPb and the corres-
ponding mutants, C95A, C95T and C188A, all show
comparable PtdIns transfer activity, indicating that C95
and C188 are not essential for PtdIns transfer (Figure
S4B,D). When NEM was present during the assay, PtdIns
transfer activity of both WT and C188A proteins was
inhibited; in contrast, the mutants, C95A and C95T were
resistant to inhibition by NEM (Figure S4B,D).
Perhaps more importantly, for both PITPs, inhibition of
transfer activity only occurs provided that membranes are
present at the time of exposure to NEM. Exposure of
either membranes or PITPs to NEM prior to their use in the
transfer assay did not inhibit lipid transfer, suggesting that
NEM can only target the C95 residue in the presence of
membranes (Figure S5A,B). These results are in agree-
ment with earlier studies (20,26). Hence, NEM inhibits
transfer activity of both PITPa and PITPb, and C95 is the
Figure 3: NEM treatment retains
PITPb at the Golgi and ER compart-
ment in NRK cells. NRK cells were
treated with 100 mM NEM for 5 min,
quenched with b-ME (20 mM) and
either fixed in 4% paraformaldehyde
before permeabilization with digitonin
(40 mg/mL) (top panels) or permeabi-
lized with digitonin on ice before fixa-
tion (bottom panels). Endogenous
PITPb was revealed by immunofluor-
escence using the rat-specific anti-
PITPb antibody 4A7. A) Cells were
fixed first and then permeabilized. B)
As (A) except that NRK cells were
treated with 100 mM NEM for 5 min.
C) cells were permeabilized with dig-
itonin first on ice and then fixed and
stained for PITPb. D) As (C) except
that NRK cells were treated with
100 mM NEM for 5 min. Bar scale:
10 mM.
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Furthermore, NEM can only access C95 when PITPa or
PITPb interact with membranes.
Resistance to inhibition by NEM of the C95
mutants in COS-7 cells
We next examined whether the C95 mutants were
resistant to inhibition by NEM in intact cells as the transfer
activity of C95 PITP mutants is resistant to inhibition by
NEM in vitro (Figure S4B,D). COS-7 cells were transfected
with PITPa-WT and PITPb-WT and their corresponding
mutants, C188 and C95 mutants. Expression levels of
PITPa-WT and its mutants were similar, and analysis of the
western blots from four independent experiments indi-
cated that PITPa expression was increased on average by
15-fold to 25-fold. By contrast, PITPb expression was only
twofold to threefold in three independent experiments.
The cells were treated with NEM and were subsequently
disrupted by sonication to prepare membrane and cytosol
fractions. Transfer activity was monitored in cytosolic
fractions of control and NEM-treated cells (Figure 4A,C).
In cells overexpressing PITPa-WT or PITPb-WT and the
corresponding mutant C188A, NEM treatment led to
inhibition of transfer activity. In contrast, transfer activity
from cytosol prepared from cells expressing the C95
mutants of PITPa and PITPb was resistant to NEM
treatment (Figure 4A,C). C95A-PITPa was also examined
in separate experiments and behaved similarly to C95T
mutant (data not shown).
We also examined the retention of PITPa and PITPb and
their mutants to the membranes on NEM treatment. In
Figure 4B (lower panel), both the PITPa-WT and the
mutant C188A were retained at the membranes but not
the C95T mutant. The cytosolic levels of PITPa and
mutants were also examined, and a slight decrease in
WT and C188A mutant was evident but not in C95T mutant
(Figure 4B, upper panel). PITPb was similarly examined for
membrane retention upon NEM treatment. A robust
retention of endogenous PITPb is observed in the vector-
only transfected cells as well as in cells expressing PITPb-
WT and C188A-PITPb. In contrast, the C95 mutants are
not retained on the membranes. The opposite situation is
observed when cytosols were examined. While a promi-
nent decrease in cytosolic PITPb is visible in cytosol
prepared from NEM-treated cells in vector-only cells,
PITPb-WT and the C188A mutant, the decrease in cyto-
solic C95 mutants is not very significant (Figure 4D, upper
panel). Thus, mutation of C95 makes both PITPa and
PITPb resistant to attack by NEM so that the proteins
Figure 4: C95 mutants of PITPa and PITPb expressed in COS-7 cells are resistant to inhibition by NEM. A and B) COS-7 cells were
transfected with vector-only cells, PITPa-WT and the mutants, C188A and C95T. The cells were treated with NEM (1 mM) for 10 min and
were subsequently disrupted to obtain cytosol and membranes. A) PtdIns transfer was measured using 40 mg/mL cytosolic protein for
60 min at 258C; B) PITPa was examined by western blot of cytosol and membranes from control and NEM-treated cells (50 mg protein per
lane). C and D) COS-7 cells were transfected with PITPb-WT and the mutants, C188A, C95T and C95A. The cells were treated with NEM
(0.5 mM) for 10 min and were subsequently disrupted to obtain cytosol and membranes. C) PtdIns transfer was measured using 80 mg/mL
cytosolic protein for 60 min at 258C; D) PITPb was examined by western blot of cytosol and membranes from control and NEM-treated
cells (50 mg protein per lane).
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of the proteins in the cytosol is unaffected.
Two tryptophan residues define the membrane-
contacting interface that is essential for membrane
docking and transfer activity in vivo
PITPs are present in the cytosol in their closed confor-
mation and undergo an open conformation on the mem-
brane surface to release its lipid cargo (Figure 1E). ATP is
not required for this process. Computational analysis tools
predict the importance of the tryptophan doublet W203-
W204, conserved in both PITPs, for docking of PITP to
membranes (Figure 1A,B), and we tested this possibility
by mutating the two tryptophan residues to alanine in both
PITPb and PITPa. The WT proteins and the WW203/
204AA mutants were expressed in COS-7 cells and trea-
ted with NEM to monitor membrane retention. Unlike
PITPa-WT and PITPb-WT (endogenous and overexpres-
sed), the WW203/204AA mutants failed to associate with
the membranes in the presence of NEM (Figure 5A,B). In
addition, the mutant proteins were inactive for PtdIns
transfer (Figure 5C,D), demonstrating the importance of
these two residues for PITP docking to the membrane.
We also examined the intracellular localization of the PITPb
mutants in COS-7 cells. PITPb-WT and the WW203/204
mutants in rats were transfected into COS-7 cells, and the
cells were treated with 100 mM NEM for 2 min prior to
fixation for immunostaining. (The monoclonal antibody
(mAb 4A7) used in these experiments is rat specific for
immunofluorescence and can therefore only detect the
transfected proteins.) Overexpressed PITPb-WT shows
colocalization with Giantin, a marker for the cis Golgi (see
insets). Staining of the nuclear envelope is also evident. As
shown with endogenous PITPb in NRK cells (Figure 3B),
a significant increase in PITPb-WT was observed at the
Golgi upon NEM treatment (compare Figure 5E and 5F).
In addition, prominent PITPb-WT staining at the nuclear
envelope, which is derived from the ER, was observed in
the NEM-treated cells (Figure 5F). However, the WW203/
204AA PITPb mutant showed a more diffuse perinuclear
localization that did not entirely overlap with the Golgi
marker (Figure 5G), and indeed, in some of the cells, no
perinuclearstainingwasobserved.Furthermorenoincrease
wasobservedattheGolgiorthenuclearenvelopeuponNEM
treatment (Figure 5H). Instead, the WW mutant showed an
increased nuclear localization in both control and NEM-
treated cells (Figure 5G,H). Expression of the WW mutant
does not affect the Golgi structure and neither does NEM
treatment of COS-7 (see inset, Golgi staining with Giantin).
Comparison of PITPa and PITPb dynamics in intact
PC12 cells
To study the relative membrane dynamics of PITPa and
PITPb in intact cells, we surveyed various cell lines for the
expression levels of PITPa and PITPb; we identified PC12
as the cell line containing PITPa as its major PITP with
significant quantities of PITPb (Figure S1). PC12 cells were
treated with 1 mM NEM for 2, 5 and 10 min, and the
cytosols were fractionated by size exclusion chromatogra-
phy. Transfer activity (Figure 6A), immunoreactivity of both
PITPs (Figure 6B) and protein content (Figure 6C) were
monitored in the individual fractions. (The amount of pro-
tein recovery is slightly less in cells treated with NEM for
10 min, and this underestimates the residual transfer
activity in this sample.) In untreated cells, PtdIns transfer
activity was coincident with the fractions containing both
PITPa and PITPb (fractions 20–24) (compare Figure 6A and
6B). In cytosol prepared from NEM-treated PC12 cells,
PtdIns transfer activity was diminished with time of
incubation but not totally obliterated (Figure 6A). Analysis
of the same fractions by western blot revealed that
although in NEM-treated cells, both PITPa and PITPb
now elute in earlier fractions on gel filtration (an indication
of inactivation), the rate of inactivation was different
(Figure 6B). Within 2 min of treatment with NEM, the
majority of PITPb now elutes in fractions 16–18. By
contrast, a substantial amount of PITPa remains in frac-
tions 20–23 at 2 min. Although there was a progressive
reduction with time of PITPa in fractions 20–23 with
a corresponding increase in immunoreactivity in the earlier
fractions, even at 10 min, some PITPa still remained in
fractions 20–23. This suggests that a population of PITPa
remained unaffected by NEM treatment in the time frame
of these experiments. This PITPa pool likely corresponds
to the residual lipid transfer activity seen in these fractions
(Figure 6A). In contrast to PITPb, inactivated PITPa has
a greater tendency to form oligomers/aggregates unlike
PITPb that mainly forms dimers (Figure 6B). In parallel, we
also examined the retention of PITPa and PITPb to
membranes. In control PC12 cells, PITPa and PITPb was
not found in membranes, and upon NEM treatment, an
increase in membrane-associated PITPa and PITPb is
evident within 2 min of NEM incubation (Figure 6D).
Reversing thiol modification of C95 restores its lipid
transfer activity
The membrane-permeant oxidizing agent DTDP can also
modify Cys residues, but unlike the NEM effect, this
modification can be reversed by b-mercaptoethanol
(b-ME). We found that, similar to NEM, in vitro DTDP
can inactivate PITP transfer activity of recombinant PITP-
WT but not the mutant C95T (Figure 7A). The DTDP-
inactivated PITP protein was incubated with a 20-fold
excess of b-ME for 10 min after which the protein was
analysed for transfer activity. Transfer activity was recov-
ered, indicating that modification of the C95 residue is
reversible (Figure 7A).
We found that the transfer activity of endogenous PITP in
cells could also be reversed after treatment with DTDP,
HL60 cells were treated with DTDP for 2 min and were
subsequently incubated for 10 min with b-ME. The cytosol
was examined for PtdIns transfer activity, and it was found
Traffic 2008; 9: 1743–1756 1749
Dynamics of PITP Association with Membranesthat, like NEM, DTDP pretreatment led to loss of transfer
activity. Inhibition because of DTDP could be fully restored
by b-ME (Figure 7B). Membrane retention of PITPb was
also evident in DTDP-treated HL60 cells, which was
reversed when cells were further incubated with b-ME
(Figure 7C). To confirm that C95 was the residue targeted
byDTDP responsiblefor inhibition of transferactivity, C95T
PITPa or PITPa-WT were expressed in COS-7 cells. The
Figure 5: Mutation of tryptophan 203/204 in PITPa and PITPb inhibits NEM-dependent retention to membranes and inhibits
PtdIns transfer. A–D) PITPa-WT and PITPb-WT and their corresponding mutants (WW203/204AA) were transfected into COS-7 cells and
treated with NEM (500 mM) for 2 min. A and B) Retention of PITPa and PITPb to membranes by NEM is not observed when the two
tryptophans are mutated to alanine. C and D) No increase in transfer activity is observed in cytosol prepared from COS-7 overexpressing
the WW mutants of PITPa (C) or PITPb (D). E–H) Overexpressed PITPb-WT but not WW-PITPb mutant is enriched at the Golgi upon NEM
treatment. COS-7 cells were transiently transfected with PITPb-WT (E and F) or the WW mutant (G and H). Forty-eight hours post
transfection, the cells were treated with 100 mM NEM for 2 min (F and H). The insets show the staining of the Golgi using Giantin
antibodies. Bar scale: 10 mM.
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reversibility, the cells were incubated for a further 10 min
with a 20-fold excess of b-ME. Subsequent analysis of
transfer activity from the cytosols of cells overexpressing
PITP-WT and the C95T mutant showed that DTDP in-
hibited PITP-WT in both vector- and in PITPa-expressing
cells. In contrast, transfer activity from the cells expressing
the C95T mutant was resistant to inhibition by DTDP. The
small inhibition observed is because of the presence of
the endogenousPITPspresentin the cells.Incubationofthe
DTDP-treated cells with b-ME led to recovery of the transfer
activity in both vector- and PITPa-expressing cells. Mem-
branes and cytosol were also examined by western blotting;
RetentionofbothendogenousandtheoverexpressedPITPa-
WT was observed upon DTDP addition but not of the C95T
mutant.Incubationwithb-MEledtoadecreaseintheamount
of PITP-WT associated with membranes (Figure 7E).
Discussion
The principal conclusion from this study is that, in intact
cells, the lipid transfer proteins PITPa and PITPb con-
stantly interact with the membrane interface to
exchange their lipid cargo (Figure 1E). Although struc-
tural analysis had implied that PITPs are exquisitely
designed to bind and transfer lipids, and they certainly
do so in vitro, it has not been previously possible to
demonstrate that PITPs undergo lipid exchange in intact
cells and if so, with what frequency. Only one previous
study investigated the behaviour of PITP in cells using
fluorescence lifetime imaging microscopy to examine
fluorescence resonance energy transfer between green
fluorescent protein-tagged PITP and BODIPY-labelled
PtdIns or PtdCho in COS-7 cells (27). There, it was found
that interaction between PITP and PtdIns or PtdCho
increases upon stimulation with EGF, and this occurred
at 20 min after EGF treatment. In this experimental
system, however, the basal dynamics could not be
measured as the experiments were conducted in chem-
ically fixed cells.
In this study, we used thiol-modifying chemicals (NEM and
DTDP) to modify a strategically located cysteine residue as
a tool to monitor interactions of PITP with membranes in
the context of intact cells. Both PITPa and PITPb contain
Figure 6: Differential inactivation of PITPa and PITPb by NEM in PC12 cells. Cells were treated with NEM for 2, 5 and 10 min, and the
cytosol was subsequently fractionated by size exclusion chromatography. The fractionated cytosol was analysed (A) for PtdIns transfer
activity and (B) by western blot analysis for their content of PITPa and PITPb. C) The protein profile (optical density) of the cytosol
fractionation showing protein recovery. D) Time-dependent retention of PITPa and PITPb to membranes prepared from PC12 cells treated
with 1 mM NEM.
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Dynamics of PITP Association with Membranesfour conserved cysteine residues at positions 95, 188, 192
and 231 in these proteins’ amino acid sequence. Previous
in vitro studies showed that in PITPa, these four residues
exhibit differential reactivities to thiol-modifying reagents
such as NEM (20). For instance, C192 and C231 do not
react with NEM, consistent with their side chains being
Figure 7: Inactivation of PITPa and PITPb by DTDP and its reversal by b-ME. A) Recombinant PITPb-WT and the C59T mutant were
incubated with DTDP (5 mM) for 10 min in the presence of liposomes. The proteins were examined immediately for transfer activity or
were further incubated with b-ME (100 mM) for 10 min prior to monitoring lipid transfer. B and C) HL60 cells were treated with DTDP
(1 mM) for 2 min, followed by b-ME (20 mM) for 10 min. B) Cytosol was analysed for PtdIns transfer and C) membranes and cytosol were
examined for PITPb content by western blot analysis. ARF1 was used as a loading control. D) COS-7 cells expressing PITPa-WT and the
C95T mutant were treated with DTDP (1 mM) for 10 min and then with b-ME (20 mM) for a further 10 min. Cytosol (80 mg/mL protein) was
examined for PtdIns transfer. E) Cytosol and membranes prepared from vector- and PITP-expressing cells treated with DTDP and
subsequently with b-ME were examined for PITP retention to membranes (50 mg protein per lane).
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Shadan et al.buried in both the open and the closed lipid-bound struc-
tures. C188 is surface exposed and can be modified with
NEM, but it is not functionally important. C95 is unique in
that it is only reactive to NEM when PITP is associated
with membranes, adopting an open conformation to
release its lipid cargo (20). We show that the in vitro
transfer activity of both PITPa and PITPb is only inhibited
when NEM is present during intermembrane transfer
(Figure S5). The inhibition results from NEM modification
of cysteine residue 95, which resides in the lipid-head-
group-binding cavity of PITP (Figure 1A–D); mutation of
C95 to either alanine or threonine makes both PITPa and
PITPb resistant to inhibition by NEM and by DTDP (Fig-
ures 4 and 7).
Within 2 min of treating HL60 or PC12 cells with NEM,
association of PITP with membranes is detected, indicat-
ing that, in intact cells, PITP molecules are constantly
sampling membranes. It must be noted that, despite the
increase in membrane association of PITPs upon NEM
treatment, a significant proportion of these proteins are
present in the cytosol (Figures 2B and 6B). This suggests
one of two possibilities: the concentration of NEM used in
this study is insufficient to result in the retention of the
total cytosolic PITP pool to the membranes and hence their
modification, or the PITP pool that has been covalently
modified by NEM at the membranes is able to dissociate
even without a bound phospholipid. The latter seems to be
the case because the cytosolic pool of PITP from NEM-
treated cells is inactivated for PtdIns transfer. Based on
theirloss of ability to transferPtdIns and PtdCho,it appears
that, within minutes of treatment with NEM, almost all the
PITP molecules present in HL60, PC12 and COS-7 cells
have been in contact with the membranes and thus had
their C95 residues exposed to NEM. Our size exclusion
chromatography data indicate that NEM-modified cytosolic
PITPs elute as dimers. This would suggest that NEM
binding has caused the PITP protein to adopt an open
conformation, similar to that found in apo-PITP (18); we
note that C95 in the apo-protein structure was reported as
being chemically modified, as evidenced by an electron
density peak 1.8 A ˚ from the SG atom [modelled as a water
molecule in the protein database (PDB) entry] (18). Apo-
PITPa forms crystallographic dimers to bury the hydropho-
bic residues within the lipid-binding cavity in the dimer
interface, and the two lipid exchange loops make contact
with the partner lipid-binding regions. It has been sug-
gested that binding of a phospholipid is required for PITPs
to fully arrive at the closed soluble conformation (28,29).
So, NEM-modified PITP likely adopts a dimeric arrange-
ment analogous to that found in the apo-PITPa structure.
The open conformation NEM-modified PITPs are likely to
dissociate from the membrane during lipid transfer more
slowly than WT PITPs. Consequently, when membranes
of NEM-treated cells are examined, some PITPs are
detected that are still membrane associated. This is not
seen in membranes prepared from control cells. When
NEM-modified PITP eventually leaves the membranes, it
forms dimers that shield its hydrophobic residues but are
not capable of PtdIns transfer. Using NEM in intact cells,
our data clearly demonstrate that the majority of PITPs
have interacted with the membrane within 10 min. This
emphasizes the dynamic nature of PITP interaction with
membranes in intact cells.
When examined by immunofluorescence microscopy that
both endogenous and overexpressed PITPb localize at the
Golgi compartment (21,23,27,30) as well as diffusely in the
cytosol. The diffuse staining is because of PITPb associ-
ating with membranous structures, most likely ER, as
demonstrated by its retention in the cell following NEM
treatment (Figure 3). As all the cellular PITPb is inactivated
upon NEM treatment, our data indicate that the Golgi pool
of this protein is in rapid dynamic equilibrium with the ER
pool. In addition, the membrane-associated PITPb is
undergoing a rapid change in conformation from open to
closed.
In PC12 cells, a small fraction of PITPa appears to be
somewhat resistant to inactivation by NEM in the 10-min
time frame studied. There could be two explanations that
are not mutually exclusive. The resistant subpopulation
could represent the nuclear pool of PITPa that is not in
close proximity to membranes and might not go through
a cycle of open and closed conformation during the 10-min
period studied in this study. Alternatively, it could repre-
sent a population of PITPa phosphorylated at Ser166,
which causes inactivation of its PtdIns transfer activity by
an unknown mechanism (31).
The first step in the process of lipid exchange is for PITP to
dock on to membrane surfaces. We identify two trypto-
phan residues that are critical for this process in intact
cells. We had previously shown that mutation of the two
tryptophans to alanine in PITPa led to loss of PtdIns
transfer activity in vitro (16). Using NEM as a tool for
trapping the open form of PITP to membranes, a measure
for docking can be monitored by assessing the retention of
PITP to membranes. Mutation of these two tryptophan
residues W203/W204 (Figure 1A) to alanine prevents
membrane association of both PITPa and PITPb. This is
coupled to the loss of lipid transfer in these mutants
indicating that, without docking to membranes, PITPs
cannot transfer lipids.
We found that the WW203/204AA mutant of PITPb is no
longer enriched in the Golgi compartment and instead is
localized in the nucleus. Although the reason behind the
redistribution of this mutant within the cell is not clear,
a possible explanation is that when WW203/204AA
mutant of PITPb is no longer retained at the Golgi, it is
free to move to the nucleus. This is not surprising as
PITPa, which is similar to PITPb in both structure and size,
also partitions into the nucleus (23). In the case of PITPb-
WT, because it preferentially localizes to the Golgi, the free
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nucleus.
In summary, this study demonstrates a continuous sam-
pling of the cellular membranes by PITPa and PITPb
making use of two tryptophan residues to initiate the
‘opening’ of the hydrophobic cavity. The two tryptophan
residues are located at the end of the helix F adjacent to
helix G that has to dislodge to open the cavity. Thus, by
inserting the two tryptophan residues into the membrane,
this would perturb the helix G. Tryptophan residues are
known to have a preference for membrane surfaces
because of the aromatic ring and its molecular shape
(32,33). Our data support a model whereby PITPs undergo
a cycle of closed and open conformation and are thus likely
to function as lipid transfer proteins in intact cells. In the
case of PITPb, our results indicate that lipid transfer takes
place between the ER and the Golgi.
Materials and Methods
Materials
Unless otherwise stated, all the tissue culture products used were from
Invitrogen or Sigma. NEM and DTDP were prepared in dimethyl sulphoxide
as stock solutions and kept in aliquots at  208C. Once thawed, the aliquots
were discarded. The anti-PITPa polyclonal antibody (Ab 674) and the anti-
PITPb monoclonal antibody (Ab 1C1) as well as the recombinant proteins
(PITPa and PITPb) were generated in-house (21). The monoclonal antibody
made against rat PITPb Ab 4A7 was used for immunofluorescence. Its
specificity was verified using small interference RNA to deplete PITPb.
Culturing of HL60, PC12 and NRK cells
HL60 cells were grown in suspension in RPMI-1640 medium containing
12.5%heat-inactivatedfoetalcalfserum(FCS),50 IU/mLpenicillin,50 mg/mL
streptomycinand2 mML -glutamine. PC12 cells were grown in suspension in
DMEM medium containing 10% heat-inactivated horse serum, 5% heat-
inactivated FCS and 2 mM L-glutamine. NRK cells were cultured in DMEM
medium containing 10% heat-inactivated FCS, 2 mML -glutamine, 50 IU/mL
penicillin and 50 mg/mL streptomycin.
Culture of COS-7 cells and transfection by
electroporation
COS-7 cells were grown in DMEM supplemented with 10% heat-inacti-
vated foetal bovine serum. The COS-7 cells (2   10
7 cells) were trypsi-
nized, washed and resuspended in 400 mL DMEM supplemented with
10% heat-inactivated foetal bovine serum. For electroporation (two pulses
of 0.220 kV and 950 mF), the cells were mixed with 10 mg of the plasmid
construct and 30 mg of Herring sperm carrier DNA. Cells were used
24–48 h post transfection.
Mutagenesis and purification of recombinant PITPa
and PITPb proteins in Escherichia coli
PITPa and PITPb were expressed using pRSETC vector (Invitrogen).
Mutagenesis was performed using the QuickChange kit from Stratagene
according to the protocol provided by the manufacturer. The constructs
were all sequenced for verification that the mutations were introduced. The
His-tagged proteins were expressed in the E. Coli strain, BL21(DE3)pLysS,
and purified using nitrilotriacetic acid–agarose (Invitrogen) as described
previously (34). The His-tagged proteins were desalted to piperazine-1,4-
bis(2-ethanesulphonic acid (PIPES) buffer (20 mM PIPES, 137 mM NaCl and
3m M KCl, pH 6.8) and stored at  808C. The same primers were used to
introduce the same mutations in PITPa and PITPb in pcDNA3.1 vector for
mammalian cell expression.
Assays for PtdIns and PtdCho transfer activity in vitro
PtdIns transferactivity wasassayed bymeasuring thetransfer of[
3H]PtdIns
from radiolabelled rat liver microsomes to unlabelled synthetic liposomes
(PtdCho:PtdIns ratio, 98:2 by molar percentage) as described previously (7).
To examine the effect of NEM on recombinant proteins, PITPs were
pretreated with NEM (0–5 mM) in the presence of liposomes and NEM was
quenched with 20-fold excess of b-ME (20–100 mM) and then assayed for
transfer activity. Percentage transfer was calculated from the total counts
present in microsomes after subtracting the number of counts transferred
in the absence of a PITP source. PtdCho transfer activity was monitored
using permeabilized HL60 cells prelabelled with [
3H]choline to label the
choline lipids, predominantly PtdCho, exactly as described (30). Transfer
activity was monitored in duplicate samples, and the error bars denote the
range of the averages. For fractions obtained after size exclusion chroma-
tography, individual fractions were analysed. All data presented are
representative of at least three independent experiments.
NEM treatment and preparation of membrane
and cytosolic fractions
The protocol used for HL60, PC12 and COS-7 cells was essentially the
same. Approximately 1–2   10
8 cells were used per treatment. COS-7
cells were used either as adherent cells or trypsinized and used in
suspension. The results were identical regardless of the protocol. Cells
were suspended in 10 mL of HEPES buffer (137 mM NaCl, 2.7 mM KCl,
20 mM HEPES, 2 mM MgCl2,1m M CaCl2, 1 mg/mL glucose and 1 mg/mL
BSA, pH 7.2) and treated with NEM or DTDP at 378C at the indicated
concentrations and times. NEM or DTDP treatment was terminated by the
addition of 20 mMb-ME or bycentrifugation and washing with 10 mL of ice-
cold PBS at 48C. The cells were resuspended in 300 mL PBS in the
presence of a protease inhibitor cocktail (Sigma). To prepare membranes
and cytosol, the cells were sonicated on ice (50 microns, 3   15 seconds)
and centrifuged for 10 min (2000   g,4 8C) to pellet the nuclei and
unbroken cells. The lysate was centrifuged for 30 min at 110 000   g at
48C to pellet the membranes, and the supernatant consisting of the
cytosolic fraction was retained for further analysis. To remove contaminat-
ing cytosolic proteins, the membranes were resuspended in 1 mL of SET
buffer (0.25 M sucrose, 1 mM ethylenediaminetetraacetic acid and 10 mM
Tris–HCl, pH 7.4), and centrifuged at 110 000   g (48C, 30 min). The
membranes were resuspended in 100 mL of SET buffer or in PBS. Protein
concentrations were determined for both the membrane and the cytosolic
fractions. The distribution of PITPs (a and b) between membranes and the
cytosol was analysed through separation of the proteins on a 12% sodium
dodecyl sulphate polyacrylamide gel followed by western blot analysis.
Fractionation of cytosol by size exclusion
chromatography and analysis of lipid transfer
For analysis of the cytosol by size exclusion chromatography, the cells were
disrupted using repeated freeze–thaw cycles. This protocol was chosen so
that the cytosol could be obtained in a small volume (150 mL). Two hundred
millilitres of confluent HL60 or PC12 cells was used per condition, and the
cell pellet was transferred into an Eppendorf tube and resuspended in
100 mL of PBS-containing protease inhibitor cocktail (Sigma). The cells
were frozen at  808C overnight. The following day, they were transferred
to a salted ice bath for 6 h in a chilled cabinet, and then, they were
transferred to  808C overnight. This process was repeated on the second
day. On the third day, the samples were rapidly thawed on ice and im-
mediately centrifuged on a bench top Optima ultracentrifuge (Beckman)
(110 000   g,3 0 m i n ,4 8C). The cytosol was carefully decanted and
recentrifuged at 15 000   g for 10 min, and 150–180 mL (2–3 mg of total
protein) was immediately loaded on a Superose 12 column 10/300; bed
volume 24 mL (GEHealthcare)and elutedwith PBS). 0.5 mL fractions were
collected. (The first 3 mL was not collected; the conversion of elution
volume to fraction number can be found in Figure 6C where both scales
are shown.) Hundred-microlitre aliquots of the individual fractions were
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the individual fractions were combined with sample buffer for western blot
analysis. For PtdIns transfer, 150 mL of a mixture of microsomes and
liposomes was added to each of the fractions and processed exactly as
described previously (7). For PtdCho transfer, 100 mL of the fraction was
analysed using the cytosol-depleted permeabilized HL60 cells as the donor
compartment exactly as described previously (30).
Treatment of NRK and COS-7 cells with NEM followed
by immunofluorescence
NRK cells were plated onto glass cover slips and washed twice with HEPES
buffer (20 mM HEPES, 137 mM NaCl, 3 mM KCl, 1 mM CaCl2,2m M MgCl2,
1 mg/mL glucose and 1 mg/ml BSA) and treated with 100 mM NEM in
HEPES buffer for 5 min at 37
oC. Twenty micromolar b-ME was added
immediately to quench the NEM. The cells were washed twice with PBS.
One set of cells were fixed with 4% paraformaldehyde and subsequently
permeabilized with digitonin (40 mg/mL) for 10 min on ice and washed with
cold PBS. A second set of cells were permeabilized with digitonin (40 mg/
mL) for 10 min on ice and washed with cold PBS before fixation with
paraformaldehyde. The cells were incubated with primary antibodies [mAb
4A7 for PITPb and GM130 (polyclonal)] as indicated, followed by fluores-
cent Alexa fluor 488 (PITPb) or 546 (GM130) conjugated secondary
antibodies (Molecular Probes). Fluorescence was recorded by excitation
at488 or 546 nm with a light source (excite 120 nm) using an Olympus IX80
microscope fitted with a  100 or a  40 oil immersion objective. Images
wereacquiredwithacharge-coupleddevicecameraORCA-ER(Hamamatsu)
cooled to  358C and controlled with the Cell^F software (Olympus).
COS-7 cells were transfected with rat PITPb-WT and the corresponding
WW203/204AA mutant using FuGene 6 transfection reagent as per
manufacturer’s recommendations (Roche Diagnostics). After 48 h, the
cells were treated with 100 mM NEM for 2 min at 378C. The cells were
prepared exactly as above for microscopy except that the cells were fixed
with 4% paraformaldehyde and subsequently permeabilized with digitonin
(40 mg/mL) for 10 min on ice and washed with cold PBS. The cells were
incubated with primary antibodies [mAb 4A7 for PITPb and Giantin (rabbit
polyclonal)] as indicated, followed by fluorescent Alexa fluor 488 (PITPb)o r
546 (Giantin) conjugated secondary antibodies (Molecular Probes).
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Figure S1: Expression levels of PITPa and PITPb in cultured cell lines.
Lysates from cell lines were prepared in Radio Immuno Precipitation Assay
buffer (RIPA) (50 mM Tris, pH 7.5; 150 mM NaCl; 1% NP-40; 0.5%
deoxycholate and 0.1% sodium dodecyl sulphate) with the addition of
protease inhibitor cocktail (Sigma). Lysates were centrifuged at 15 000   g
for 30 min at 48C to remove cell debris, and proteins were separated by
SDS–PAGE, followed by western blot analysis using isoform-specific
antibodies. PITPa and PITPb were quantified by western blot using
recombinant PITPa and PITPb-sp1 as standards. PITPb was detected with
Ab 1C1, which detects both splice variants (21). On each gel, a known
concentration range of recombinant PITP proteins were included and the
amount of PITP proteins present in the sample calculated based from them.
Cell lines used were HL60 cells, human promyelocytic leukaemia; PC12
cells, derived from a rat pheochromocytoma, a tumour of the adrenal gland;
NRK, normal rat kidney epithelial cells; RBL-2H3, rat basophilic leukaemia;
WKPT-02903 CL2, immortalized from the Wistar rat proximal convoluted
tubule; HeLa, human epithelial cell derived from a cervical tumour; COS-7,
African green monkey kidney fibroblast-like cell line.
Figure S2: Inhibition of PtdIns transfer activity of PITPb and its
retention to membranes depend on NEM concentration and incuba-
tion time. HL60 cells were treated with the indicated concentrations of
NEM for 10 min (A and B) or 2 min (C and D). Membranes and cytosol were
prepared. PtdIns transfer activity in control and NEM-treated HL60 cell
cytosol (100 mg protein per assay) was assessed (A and C). B) Immunoblot
of the membranes and cytosol fractions from (A) using an anti-PITPb
antibody, Ab 1C1. D) Immunoblot of PITPb in membrane fractions treated
with a range of NEM concentrations for 2 min.
Figure S3: NEM treatment retains PITPb at the Golgi and ER com-
partment in NRK cells. NRK cells were treated with 100 mM NEM for
5 min,quenchedwithb-ME(20 mM), permeabilizedwith digitonin(40 mg/mL)
on ice and subsequently fixed with 4% paraformaldehyde. Endogenous
PITPb was revealed by immunofluorescence using the rat-specific anti-PITPb
monoclonal antibody 4A7 and the Golgi by antibody to GM130 (A–C) control
NRK cells; (D–F) NRK cells were treated with 100 mM NEM for 5 min. A and
D)PITPb,green;BandE)GM130,red;CandF)OverlayofPITPb andGM130.
Bar scale: 10 mM.
Figure S4: Inhibition of PtdIns transfer activity by NEM is dependent
on Cys95. Cys95 was mutated to alanine or threonine, and cys188 was
mutated to alanine. PITPa and PITPb mutants were purified as described in
the Materials and Methods. A and C) One microgram of each protein was
analysed by SDS–PAGE and Coomassie staining to examine their purity;
B and D) PITP proteins (WT and mutants) were assayed for PtdIns transfer
in the presence and absence of NEM (5 mM). A and B) PITPb and its
mutants and C and D) PITPa and its mutants.
Figure S5: NEM can only inhibit PtdIns transfer activity provided that
membranes and PITP proteins are both present during the assay. The
recombinant proteins were assayed for PtdIns transfer after the following
treatments. Filled circles, PITP protein incubated with varying concentra-
tions of NEM in the absence of membranes; NEM was subsequently
quenched with b-ME prior to assay for PtdIns transfer assay; Open circles,
PITP proteins assayed for transfer activity in the presence of NEM with no
pretreatment. Filled squares, membranes incubated with varying concen-
trations of NEM; NEM was quenched with b-ME, and the membranes were
used as the donor compartment for PtdIns transfer. A) PITPb and B) PITPa.
Please note: Wiley-Blackwell are not responsible for the content or
functionality of any supporting materials supplied by the authors. Any
queries (other than missing material) should be directed to the correspond-
ing author for the article.
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